Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · IEX Real-Time Price · USD
0.405
-0.012 (-2.76%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Aethlon Medical Market Cap
Aethlon Medical has a market cap or net worth of $5.63 million as of July 22, 2024. Its market cap has decreased by -46.37% in one year.
Market Cap
5.63M
Enterprise Value
717.73K
1-Year Change
-46.37%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since July 13, 2015, Aethlon Medical's market cap has decreased from $68.00M to $5.63M, a decrease of -91.72%. That is a compound annual growth rate of -24.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 5.60M | 1.82% |
| Dec 29, 2023 | 5.50M | -12.70% |
| Dec 30, 2022 | 6.30M | -77.97% |
| Dec 31, 2021 | 28.60M | -4.35% |
| Dec 31, 2020 | 29.90M | 2,035.71% |
| Dec 31, 2019 | 1.40M | -95.27% |
| Dec 31, 2018 | 29.60M | 73.10% |
| Dec 29, 2017 | 17.10M | -47.22% |
| Dec 30, 2016 | 32.40M | -37.33% |
| Dec 31, 2015 | 51.70M | -23.97% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonoma Pharmaceuticals | 5.85M |
| Titan Pharmaceuticals | 5.81M |
| Ainos | 5.75M |
| Oragenics | 5.69M |
| PolyPid | 5.67M |
| Biomerica | 5.59M |
| FSD Pharma | 5.59M |
| Synaptogenix | 5.54M |